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Spinal Anesthesia or General Anesthesia for Hip Surgery
in Older Adults
M.D. Neuman, R. Feng, J.L. Carson, L.J. Gaskins, D. Dillane, D.I. Sessler, F. Sieber, J. Magaziner, E.R. Marcantonio,
S. Mehta, D. Menio, S. Ayad, T. Stone, S. Papp, E.S. Schwenk, N. Elkassabany, M. Marshall, J.D. Jaffe, C. Luke,
B. Sharma, S. Azim, R.A. Hymes, K.-J. Chin, R. Sheppard, B. Perlman, J. Sappenfield, E. Hauck, M.A. Hoeft,
M. Giska, Y. Ranganath, T. Tedore, S. Choi, J. Li, M.K. Kwofie, A. Nader, R.D. Sanders, B.F.S. Allen, K. Vlassakov,
S. Kates, L.A. Fleisher, J. Dattilo, A. Tierney, A.J. Stephens‑Shields, and S.S. Ellenberg, for the REGAIN Investigators*

a bs t r ac t
BACKGROUND

The effects of spinal anesthesia as compared with general anesthesia on the ability to
walk in older adults undergoing surgery for hip fracture have not been well studied.
METHODS

We conducted a pragmatic, randomized superiority trial to evaluate spinal anesthesia as compared with general anesthesia in previously ambulatory patients 50
years of age or older who were undergoing surgery for hip fracture at 46 U.S. and
Canadian hospitals. Patients were randomly assigned in a 1:1 ratio to receive spinal or general anesthesia. The primary outcome was a composite of death or an
inability to walk approximately 10 ft (3 m) independently or with a walker or cane
at 60 days after randomization. Secondary outcomes included death within 60 days,
delirium, time to discharge, and ambulation at 60 days.
RESULTS

A total of 1600 patients were enrolled; 795 were assigned to receive spinal anesthesia and 805 to receive general anesthesia. The mean age was 78 years, and 67.0% of
the patients were women. A total of 666 patients (83.8%) assigned to spinal anesthesia and 769 patients (95.5%) assigned to general anesthesia received their assigned anesthesia. Among patients in the modified intention-to-treat population for
whom data were available, the composite primary outcome occurred in 132 of 712
patients (18.5%) in the spinal anesthesia group and 132 of 733 (18.0%) in the general anesthesia group (relative risk, 1.03; 95% confidence interval [CI], 0.84 to 1.27;
P = 0.83). An inability to walk independently at 60 days was reported in 104 of 684
patients (15.2%) and 101 of 702 patients (14.4%), respectively (relative risk, 1.06; 95%
CI, 0.82 to 1.36), and death within 60 days occurred in 30 of 768 (3.9%) and 32 of
784 (4.1%), respectively (relative risk, 0.97; 95% CI, 0.59 to 1.57). Delirium occurred
in 130 of 633 patients (20.5%) in the spinal anesthesia group and in 124 of 629
(19.7%) in the general anesthesia group (relative risk, 1.04; 95% CI, 0.84 to 1.30).

The authors’ full names, academic degrees, and affiliations are listed in the
Appendix. Dr. Neuman can be contacted
at neumanm@pennmedicine.upenn.edu
or at the Department of Anesthesiology
and Critical Care, University of Pennsylvania Perelman School of Medicine, 308
Blockley Hall, 423 Guardian Dr., Philadelphia PA, 19106.
*The REGAIN investigators are listed in
the Supplementary Appendix, available
at NEJM.org.
This article was published on October 9,
2021, and updated on November 25, 2021,
at NEJM.org.
N Engl J Med 2021;385:2025-35.
DOI: 10.1056/NEJMoa2113514
Copyright © 2021 Massachusetts Medical Society.
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CONCLUSIONS

Spinal anesthesia for hip-fracture surgery in older adults was not superior to general anesthesia with respect to survival and recovery of ambulation at 60 days. The
incidence of postoperative delirium was similar with the two types of anesthesia.
(Funded by the Patient-Centered Outcomes Research Institute; REGAIN ClinicalTrials.gov number, NCT02507505.)
n engl j med 385;22

nejm.org

November 25, 2021

2025

The New England Journal of Medicine
Downloaded from nejm.org at THOMAS JEFFERSON UNIVERSITY on August 25, 2022. For personal use only. No other uses without permission.
Copyright © 2021 Massachusetts Medical Society. All rights reserved.

n e w e ng l a n d j o u r na l

The

N

A Quick Take
is available at
NEJM.org

early all patients with hip fracture undergo surgery,1 most commonly
with spinal anesthesia or general anesthesia.2 Observational studies have suggested
that spinal anesthesia may be associated with
lower risks of death,3 delirium,4,5 and major
medical complications6 and with shorter lengths
of stay in the hospital than general anesthesia.7
Randomized trials have shown conflicting results regarding differences in outcomes according to anesthesia type, but most of these trials
were conducted more than 30 years ago and do
not reflect current practice, had small numbers
of participants, or were not designed to assess
outcomes beyond the hospital stay.8 Patients may
view recovery of independence in walking after
hip fracture as a priority,9 but studies evaluating
the effect of anesthesia technique on this outcome are lacking.8
We conducted a trial to evaluate the recovery
of walking ability after receipt of spinal as compared with general anesthesia for hip-fracture
surgery in older adults who could walk independently before the fracture. We hypothesized that
patients assigned to receive spinal anesthesia
would be more likely to be alive and walking
independently at 60 days than those assigned to
receive general anesthesia.

Me thods
Trial Design and Oversight

We conducted the Regional versus General Anesthesia for Promoting Independence after Hip
Fracture (REGAIN) trial, a multicenter, pragmatic, randomized superiority trial funded by the
Patient-Centered Outcomes Research Institute.
The trial design has been described previously.10
The trial was investigator-initiated and was planned
and conducted with the participation of patients
and stakeholder organizations (the Center for Advocacy for the Rights and Interests of the Elderly
and the Gerontological Society of America).11
There was no commercial participation in the
trial. The institutional review board of the University of Pennsylvania, the institution that oversaw the conduct of the trial, approved the protocol (available with the full text of this article at
NEJM.org) and was the institutional review board
of record for 11 sites; approval at other sites was
obtained through local institutional review
boards.12 Written informed consent was obtained
2026
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from the patients or, for patients who could not
provide consent, from their health care proxy.
The trial was conducted in accordance with the
Declaration of Helsinki and Good Clinical Practice guidelines. The authors vouch for the accuracy and completeness of the data and for the
fidelity of the trial to the protocol.
Trial Population

Trial staff at 46 hospitals in the United States
and Canada reviewed emergency department registration lists, hospital admission lists, and surgical case schedules to identify adults who were
50 years of age or older and were scheduled to
undergo surgical repair of a clinically or radiographically diagnosed femoral neck, intertrochanteric, or subtrochanteric hip fracture. Inclusion and exclusion criteria were evaluated by
means of in-person interview and medical record
review. Patients were excluded if they had not
been able to walk approximately 10 ft (3 m) or
across a room without the assistance of another
person before the fracture, as reported by the
patient or by a proxy who knew the patient; if a
concurrent procedure that was not amenable to
spinal anesthesia was planned; if the fracture
was periprosthetic; if the patient was at risk for
malignant hyperthermia; or if the patient had
contraindications to spinal anesthesia (coagulopathy, use of anticoagulant or antiplatelet
medications, 13,14 critical or severe aortic stenosis, a high risk of infection at the spinal needle
insertion site, or elevated intracranial pressure).
Patients were also excluded if they had previously participated in the trial or if they were
considered to be unsuitable for randomization
by the surgeon or anesthesiologist on the basis
of the physician’s clinical assessment. Patients
who were judged to have delirium before surgery
were not excluded if consent would be obtained
from a proxy or the patient.
Patients were randomly assigned in a 1:1 ratio,
with the use of permuted block randomization
with variable block sizes, to receive either spinal
anesthesia or general anesthesia.15,16 Randomization was stratified according to hospital, sex,
and fracture location (femoral neck vs. intertrochanteric or subtrochanteric fracture) and was
performed centrally through an online datamanagement system. Site staff obtained each
randomization assignment from the data-management system Web portal and communicated it to
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the treating anesthesia team. Site staff were instructed to obtain and communicate the assignment on the day of surgery, immediately before
the start of anesthesia care. When site personnel
could not access the online system, the randomization assignment was communicated by telephone to site staff by the principal investigator
or the lead project manager.
Trial Treatment

Anesthesia was administered by the usual clinical anesthesia staff at each site. For patients assigned to receive spinal anesthesia, providers received instructions to administer a single-injection
spinal anesthetic with sedation as needed for
patient comfort; sedation was adjusted to ensure
an Observer’s Assessment of Alertness/Sedation
(OAAS) scale17 score between 5 (“Responds readily to name spoken in normal tone”) and 2 (“Responds only after mild shaking or prodding”).18
Crossover to general anesthesia was permitted
on the basis of clinical circumstances or patient
request. For patients assigned to general anesthesia, providers were instructed to use an inhaled anesthetic agent for maintenance, with the
choice of agent conforming to their usual practice, and to use an endotracheal tube, supraglottic airway, or another device for airway management in accordance with local practice. All other
aspects of care were determined by the clinical
team. Trial participants and treating clinicians
were aware of the treatment assignments.
Outcomes

The primary outcome was a composite of death
or an inability to walk 10 feet (3 m) or across a
room independently or with a walker or cane but
without the assistance of another person at approximately 60 days after randomization. Death
was included in the primary outcome to account
for potential survivorship bias.19,20 Data on the
primary outcome were obtained through telephone interviews performed by trial staff who
were unaware of the treatment assignments; data
collection from caregivers or other proxies was
permitted when participants were unable to complete the outcome interview. Interviews were
recorded and randomly audited. For patients
who could not be contacted by telephone for the
60-day interview, we ascertained vital status
from subsequent interviews; for U.S. patients for
whom vital status could not be ascertained, we
n engl j med 385;22

searched the National Death Index through 2019,
the most recent year available.
Secondary outcomes included the two components of the primary outcome (death by 60
days after randomization and new inability to
walk at 60 days among survivors); new-onset
delirium, with delirium assessed as present or
absent on the basis of the 3-Minute Diagnostic
Interview for CAM (Confusion Assessment
Method)–defined Delirium (3D-CAM21; measurements were conducted before randomization and
once daily over each of the first 3 days after
surgery by trained site staff); and time from
randomization to hospital discharge. Exploratory
outcomes included medical complications during hospitalization, ascertained by site trial staff
on the basis of medical record review using
standardized definitions; time to first ambulation; discharge disposition (i.e., discharge to home
or retirement home, nursing home or skilled
nursing facility, rehabilitation or acute care hospital, or hospice or other location); residential
location at 60 days; and functional status at 60
days, as measured with the 12-item World Health
Organization Disability Assessment Schedule 2.0.22
Data on serious adverse events were reviewed by
an internal monitoring committee for severity,
expectedness, and relatedness to treatment.
Data were reviewed at prespecified intervals
by an independent data and safety monitoring
board, the members of which were aware of the
treatment assignments. Additional details of the
trial monitoring plan are provided in the Supplementary Appendix, available at NEJM.org. The
principal investigator, statisticians, coordinating
center staff, and coinvestigators remained unaware of the treatment assignments until the
database was locked for analysis.
Statistical Analysis

We estimated that a sample of 1600 patients
would provide 80% power to detect a 0.78 relative risk of the primary outcome among patients
assigned to spinal anesthesia as compared with
those assigned to general anesthesia, at a twosided significance level of 0.05. The calculation
was performed under the assumption that the
primary outcome would occur in 34.2% of the
patients in the general anesthesia group,23 loss
to follow-up would be 5%, and 5% of the patients assigned to spinal anesthesia would cross
over to general anesthesia.24,25 The primary analy-
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sis and analyses of all secondary and exploratory
outcomes included patients in the modified intention-to-treat population for whom complete data
were available for the relevant outcomes. The
modified intention-to-treat population included
all patients who underwent randomization and
did not die before receiving treatment. Patients
were included in the analysis according to their
original treatment assignment. We performed a
Mantel–Haenszel test, stratified according to
fracture location (femoral neck fracture vs. intertrochanteric or subtrochanteric fracture), sex,
and country (United States vs. Canada), to compare the risks of the primary outcome in each
group. Although randomization was stratified
according to fracture location, sex, and hospital,
recruitment at many sites was too low to permit
stratification of the analysis according to hospital. Superiority testing was based on a two-sided
significance level of 0.05.
Secondary outcomes were analyzed with the
use of approaches similar to those used in our
primary analysis for binary data. For time-toevent data, we used competing-risk Cox regression and confirmed the proportional hazards
assumption with log–log survival plots and
Schoenfeld residuals. Patients who were assessed
as having delirium before randomization on the
basis of 3D-CAM were eligible for enrollment if
proxy consent could be obtained, and these patients were excluded from the analysis of incident delirium but were included in analyses of
other outcomes. There was no plan for adjustment of the width of confidence intervals for
multiple comparisons in analyses of secondary
outcomes, and no definite conclusions can be
drawn from these results.
To assess the effect of missing data on the
findings for the primary outcome, we performed
an inverse-probability–weighted analysis26 that
weighted each patient according to the inverse
probability of being a “complete case,” as estimat
ed on the basis of 10 prerandomization factors
(age, sex, enrollment country, fracture location,
and status with respect to pulmonary disease,
cancer, diabetes, coronary artery disease, cerebrovascular disease, and dementia). We performed
an instrumental variable analysis to estimate the
per-protocol effect27 of spinal anesthesia as compared with general anesthesia on the primary
outcome (see the Supplementary Appendix).28
For the primary outcome, we explored prespeci2028

n engl j med 385;22

of

m e dic i n e

fied patient characteristics (sex, fracture type,
country of enrollment, reliance on assistive devices to ambulate before fracture, age [≥85 years
vs. <85 years], location of residence before fracture, and status with respect to dementia,
chronic pulmonary disease, and coronary artery
disease or heart failure). We conducted exploratory subgroup analyses for interactions with
P values of 0.20 or lower. Data are current as of
June 17, 2021. Analyses were performed with the
use of SAS software, version 9.4 (SAS Institute).

R e sult s
Patients and Treatment

Between February 12, 2016, and February 18,
2021, we screened 22,022 patients for eligibility;
1848 provided informed consent, and 248 withdrew consent before randomization. A total of
7.4% of screened patients (1621 of 22,022) were
excluded on the basis of physician decision or
surgeon nonparticipation. Of the 1600 patients
who were randomly assigned to a treatment
group, 795 were assigned to receive spinal anesthesia and 805 were assigned to receive general
anesthesia (Fig. 1). The characteristics of the
patients were similar in the two treatment
groups (Table 1). The mean age of the patients
was approximately 78 years, 33.0% were men,
and 7.6% were Black.
Of the 795 patients who were assigned to the
spinal anesthesia group, 119 (15.0%) instead
received general anesthesia. Reasons for administration of general anesthesia were an inability
to place a spinal block (52 patients), clinician
selection of general anesthesia (29 patients),
patient or proxy request (18 patients), crossover
to general anesthesia after spinal block placement (e.g., due to block failure or intraoperative
events; 12 patients), and communication issues
(e.g., due to case rescheduling or shift changes;
7 patients); no reason was provided in 1 instance.
Ten patients who had been assigned to receive
spinal anesthesia (1.3%) withdrew consent before surgery; data collection for these patients
stopped at withdrawal. Of the 502 patients with
available data on the maximum depth of sedation during spinal anesthesia, 431 (85.9%) had
an OAAS score between 5 (lighter sedation) and
2 (deeper sedation), and 71 (14.1%) had a deeper
level of sedation.
Of the 805 patients assigned to receive gen-
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Figure 1. Screening, Enrollment, Randomization,
and Follow-up.
The other reasons for patients not meeting the eligibility criteria included no surgery planned, history of malignant hyperthermia, previous participation in the trial,
elevated intracranial pressure, active skin infection at
the needle insertion site, and incarceration. In addition
to the 1600 randomization codes generated for enrolled
patients, 7 codes were unintentionally generated because
of technical errors in operating the screening log for patients who had been excluded from participation at
screening; these patients had no data collected and
were not included in the trial sample.

eral anesthesia, 28 (3.5%) instead received spinal
anesthesia; reasons for administration of spinal
anesthesia were clinician selection of spinal anesthesia (15 patients), patient or proxy request
(7 patients), and communication issues (i.e., as
a result of case rescheduling or shift changes;
4 patients); in 2 cases, no reason was provided.
Seven patients who had been assigned to general anesthesia (0.9%) withdrew consent before
surgery; no outcome data were collected for these
7 patients after withdrawal. The median total
anesthesia time was 132 minutes (interquartile
range, 102 to 165) in the spinal anesthesia group
and 131 minutes (interquartile range, 103 to
165) in the general anesthesia group (Table S1 in
the Supplementary Appendix).
One patient in the general anesthesia group
died after randomization but before the start of
anesthesia; data from this patient were not included in the outcome analyses. Data on the
primary outcome were available for 1445 of the
1599 remaining patients (90.4%) in the modified
intention-to-treat analysis (Tables 2 and S2). For
patients assigned to spinal anesthesia, the median time from randomization to the primary
outcome interview was 59 days (interquartile
range, 55 to 65); for patients assigned to general
anesthesia, it was 60 days (interquartile range,
54 to 66).
Outcomes

The composite primary outcome of death or a
new inability to walk independently occurred in
132 of 712 patients (18.5%) who received spinal
anesthesia and in 132 of 733 patients (18.0%)
who received general anesthesia (complete case
analysis: relative risk, 1.03; 95% confidence
interval [CI], 0.83 to 1.28; inverse-probability–
weighted analysis: relative risk, 1.03; 95% CI,
n engl j med 385;22

nejm.org

22,022 Patients were assessed for eligibility
20,422 Were excluded
12,915 Did not meet eligibility
criteria
2,497 Were receiving contraindicating anticoagulant
medication
1,892 Had coagulopathy
1,369 Had incorrect fracture
type
1,328 Had physician who
declined participation
1,193 Were unable to provide
consent and did not
have proxy available
756 Were <50 yr of age
639 Were unable to walk
independently before
fracture
397 Had concurrent surgery
282 Had severe aortic
stenosis
526 Had other reason
2,036 Had multiple reasons
3,565 Declined consent or had
proxy decline consent
2,660 Were not enrolled because
staff was unavailable
521 Had language barrier
293 Had surgeon who was not
participating in trial
14 Had multiple administrative reasons
454 Had other or unknown
reason
1600 Underwent randomization

795 Were assigned to receive spinal
anesthesia
666 Received spinal anesthesia
119 Received general anesthesia
64 Had spinal block attempted or
placed, crossed over to general
55 Did not have spinal block
attempted
10 Withdrew before surgery or
did not have data on anesthesia
type received

805 Were assigned to receive general
anesthesia
769 Received general anesthesia
28 Received spinal anesthesia
1 Died before receipt of anesthesia
7 Withdrew before surgery or
did not have data on anesthesia
type received

712 Had data available for primary
Were included in primary analysis
outcome
30 Died on or before day 60
682 Completed follow-up interview
83 Did not have data available for
primary outcome
13 Withdrew before interview
56 Were unable to be contacted
within 60-day interview window
14 Were contacted but walking
status was unknown

734 Had data available for primary
outcome
33 Died on or before day 60
701 Completed follow-up interview
71 Did not have data available for
primary outcome
1 Withdrew before interview
44 Were unable to be contacted
within 60-day interview window
16 Were contacted but walking
status was unknown

712 Were included in the primary
analysis
83 Were excluded owing to missing
60-day data

733 Were included in the primary
analysis
72 Were excluded
71 Were missing 60-day data
1 Died before receipt of anesthesia
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Table 1. Characteristics of the Patients Who Underwent Randomization.*
Spinal Anesthesia
(N = 795)

Characteristic

General Anesthesia
(N = 805)

Age at randomization — yr†

77.7±10.7

78.4±10.6

Male sex — no. (%)

258 (32.5)

270 (33.5)

White

683/762 (89.6)

691/774 (89.3)

Black

55/762 (7.2)

67/774 (8.7)

Other or more than one race

24/762 (3.1)

16/774 (2.1)

15/750 (2.0)

12/763 (1.6)

210 (26.4)

212 (26.3)

Chronic pulmonary disease

124/795 (15.6)

100/804 (12.4)

Diabetes mellitus

155/795 (19.5)

142/804 (17.7)

Race — no./total no. (%)‡

Hispanic ethnic group — no./total no. (%)‡
Enrolled at a non-U.S. site — no. (%)
Coexisting conditions — no./total no. (%)

Disseminated cancer
Coronary artery disease
Cerebrovascular disease
Dementia
Creatinine level >2 mg/dl or current dialysis

60/795 (7.5)

50/804 (6.2)

118/795 (14.8)

119/804 (14.8)

80/795 (10.1)

66/804 (8.2)

109/795 (13.7)

94/804 (11.7)

47/790 (5.9)

41/797 (5.1)

American Society of Anesthesiologists Physical Status
Classification — no./total no. (%)
I, no systemic disease

22/782 (2.8)

18/793 (2.3)

II, mild systemic disease

229/782 (29.3)

270/793 (34.0)

III, severe systemic disease

486/782 (62.1)

463/793 (58.4)

45/782 (5.8)

42/793 (5.3)

Femoral neck

406/795 (51.1)

409/804 (50.9)

Intertrochanteric

355/795 (44.7)

350/804 (43.5)

34/795 (4.3)

45/804 (5.6)

3D-CAM assessment positive for delirium before randomization
— no./total no. (%)

96/746 (12.9)

104/753 (13.8)

Used assistive device to ambulate before fracture — no./total no.
(%)

249/779 (32.0)

248/793 (31.3)

688/748 (92.0)

690/763 (90.4)

60/748 (8.0)

73/763 (9.6)

IV, severe systemic disease that is a constant threat to life
Final confirmed fracture type — no./total no. (%)§

Subtrochanteric or multiple locations

Preadmission residence — no./total no. (%)
Home or retirement home
Nursing home or other location

*	Plus–minus values are means ±SD. To convert the values for creatinine to micromoles per liter, multiply by 88.4. 3D-CAM
denotes 3-Minute Diagnostic Interview for CAM (Confusion Assessment Method)–Defined Delirium.
†	Data on age were missing for 1 patient in the general anesthesia group.
‡	Race and ethnic group were reported by the patients or their proxies.
§	Randomization was stratified on the basis of provisional fracture-type data that were subsequently confirmed by medical
record review; final confirmed fracture-type data were not available for 1 patient who had been assigned to the femoral
neck fracture stratification group for randomization.

0.84 to 1.27; P = 0.83) (Table 2). We obtained signment (Table S3). The percentages of patients
similar findings in sensitivity analyses that ac- with each component of the primary outcome at
counted for nonadherence to the anesthesia as- 60 days were also similar in the two treatment
2030
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Table 2. Primary Outcome and Prespecified Secondary Outcomes (Modified Intention-to-Treat Population).*

Outcome

Spinal
Anesthesia
(N = 795)

General
Anesthesia
(N = 804)

Relative Risk
(95% CI)†

P
Value†

132/712 (18.5)

132/733 (18.0)

1.03 (0.84–1.27)

0.83

Primary outcome
Death or inability to walk without human assistance at 60 days — no./total no. (%)
Secondary outcomes‡
32/784 (4.1)

0.97 (0.59–1.57)

Inability to walk without human assistance at 60
104/684 (15.2)
days among survivors — no./total no. (%)

Death by 60 days — no./total no. (%)§

30/768 (3.9)

101/702 (14.4)

1.06 (0.82–1.36)

3D-CAM assessment positive for new-onset
delirium — no./total no. (%)¶

124/629 (19.7)

1.04 (0.84–1.30)

130/633 (20.5)

Hazard Ratio (95% CI)‖
Median time from randomization to discharge,
according to enrollment location (IQR)
— days**
Canada

6 (4–9)

6 (5–10)

0.92 (0.76–1.10)

United States

3 (2–5)

3 (3–5)

1.06 (0.96–1.16)

*	The modified intention-to-treat population included all patients who underwent randomization with the exception
of 1 patient who died before receiving treatment. Patients were included in the analysis according to their original
treatment assignment. Results shown for the primary outcome comparison reflect inverse-probability weighting to
account for missing outcome data; the variables included in the inverse-probability–weighting model were age, sex,
country, fracture type, pulmonary disease, cancer, diabetes, coronary artery disease, cerebrovascular disease, and
dementia. All other comparisons were performed by complete case analysis. IQR denotes interquartile range.
†	Relative risks and P values were calculated with a Mantel–Haenszel test with adjustment for sex, fracture type, and
country of enrollment.
‡	The widths of confidence intervals for secondary outcomes have not been adjusted for multiple comparisons.
§	For patients who could not be contacted for the 60-day interview, vital status at 60 days was ascertained from subsequent planned trial interviews and from the U.S. National Death Index.
¶	This outcome was assessed only among patients who had a negative 3D-CAM assessment for delirium before randomization.
‖	Hazard ratios were calculated with a Cox proportional hazards model with adjustment for sex and fracture type.
**	Differences between the United States and Canada reflect differences in practice. For patients enrolled in Canada,
data were available for 210 patients in the spinal anesthesia group and 211 in the general anesthesia group; for patients enrolled in the United States, the corresponding numbers were 585 and 593.

groups. The percentages of patients with the
primary outcome in each treatment group were
similar across participating sites (Table S4).
New-onset postoperative delirium occurred in
130 of 633 patients (20.5%) assigned to spinal
anesthesia and in 124 of 629 patients (19.7%)
assigned to general anesthesia (relative risk,
1.04; 95% CI, 0.84 to 1.30); other secondary
outcomes were also similar in the two treatment
groups (Table 2). The primary outcome was
similar across subgroups as judged by visual inspection of descriptive numerical data (Table 3).
Death during hospitalization occurred in 5 of
782 patients assigned to spinal anesthesia (0.6%)
and in 13 of 790 patients assigned to general
anesthesia (1.6%). Acute kidney injury occurred
n engl j med 385;22

in 32 of 709 patients (4.5%) assigned to spinal
anesthesia, and admission to a critical care unit
occurred in 18 of 783 (2.3%); the corresponding
numbers among the patients assigned to general
anesthesia were 55 of 726 (7.6%) and 29 of 793
(3.7%) (Table 4). Table S5 lists the serious adverse events according to treatment group; the
incidence of adverse events was similar in the
two groups.

Discussion
In this pragmatic randomized trial involving 1600
older adults undergoing hip-fracture surgery, the
incidence of death or a new inability to walk 60
days after randomization did not differ signifi-
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Table 3. Subgroup Analyses for the Primary Outcome (Modified Intention-to-Treat Population).
Spinal Anesthesia
(N = 795)

Subgroup*

General Anesthesia
(N = 804)

Relative Risk
(95% CI)†

no. of patients (%)
Age
<85 yr

63/509 (12.4)

67/499 (13.4)

0.93 (0.67–1.27)

≥85 yr

69/203 (34.0)

65/234 (27.8)

1.25 (0.94–1.66)

Present

17/109 (15.6)

22/88 (25.0)

0.64 (0.35–1.17)

Absent

115/603 (19.1)

110/645 (17.1)

1.11 (0.88–1.41)

History of chronic pulmonary disease

History of congestive heart failure or coronary
artery disease
Present

21/103 (20.4)

31/110 (28.2)

0.76 (0.47–1.23)

Absent

111/609 (18.2)

101/623 (16.2)

1.12 (0.88–1.44)

*	Selected subgroups of interest are shown.
†	Relative risks were calculated with a Mantel–Haenszel test with adjustment for sex, fracture type, and country.

cantly between patients assigned to receive spinal anesthesia and those assigned to receive general anesthesia. Secondary outcomes, including
death within 60 days, new inability to walk at
60 days among survivors, incident delirium, and
time from randomization to discharge, did not
differ substantially according to anesthesia type.
The incidences of death during hospitalization,
acute kidney injury, and postoperative critical
care admission were low but differed between
the treatment groups.
Trials evaluating spinal anesthesia as compared with general anesthesia for hip-fracture
surgery have primarily assessed differences in
intraoperative events29,30 and in-hospital complications31-33 and have not been powered to test for
differences in outcomes beyond hospital discharge. We evaluated recovery of the ability to
walk 10 ft or across a room without the assistance of another person, an outcome that is of
importance to patients and families,9 and delirium, an outcome that our patient partners
identified as a priority.11 We recruited patients
from diverse academic and community hospitals.
Fewer than 4% of all patients with hip fractures
in the United States are Black,34 and Black patients made up approximately 8% of our trial
population.
Limitations of our trial include a considerable
amount of missing outcome data; however, the
results of sensitivity analyses that accounted for
2032

n engl j med 385;22

missing data were similar to those in the primary analysis. The primary outcome occurred in
a lower percentage of patients than had been
anticipated when the trial was planned. This
reduced power and may have occurred as a result
of enrollment of patients into the trial who were
healthier than anticipated. Although approximately 15% of the patients who had been randomly
assigned to receive spinal anesthesia crossed
over to general anesthesia, our main findings
persisted in an instrumental variable analysis
that accounted for nonadherence to the assigned
treatment. Nevertheless, the rate of nonadherence may have reduced the power to detect differences between the groups. An inability to
place a spinal block was the most common reason for nonadherence, followed by clinician selection of the anesthesia type and patient or proxy
request for one anesthesia type. Since we aimed
to compare anesthetic regimens as they are used
in typical practice,18 we allowed sedation regimens to be given to patients receiving spinal
anesthesia in order to follow usual practices,
and therefore these practices varied across sites.
This heterogeneity may have limited our ability
to detect differences in outcomes between the
groups. A previous trial showed similar clinical
outcomes with deeper as compared with lighter
sedation regimens during spinal anesthesia.35,36
Finally, one component of the composite primary outcome (walking independently) was con-
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Table 4. Exploratory Outcomes (Modified Intention-to-Treat Population).
Spinal Anesthesia
(N = 795)

General Anesthesia
(N = 804)

Death

5/782 (0.6)

13/790 (1.6)

Myocardial infarction*

6/783 (0.8)

9/793 (1.1)

Nonfatal cardiac arrest

2/780 (0.3)

0/784

Stroke*

5/783 (0.6)

7/793 (0.9)

Pneumonia*

8/783 (1.0)

16/793 (2.0)

Pulmonary edema*

9/783 (1.1)

8/793 (1.0)

Pulmonary embolism*

4/783 (0.5)

5/793 (0.6)

Unplanned postoperative intubation

4/783 (0.5)

7/793 (0.9)

32/709 (4.5)

55/726 (7.6)

Outcome
Outcomes in the hospital
Complications — no./total no. (%)

Acute kidney injury*
Surgical-site infection†

2/783 (0.3)

Urinary tract infection*

35/783 (4.5)

28/793 (3.5)

Postoperative transfusion

0/793

130/782 (16.6)

146/793 (18.4)

Any return to the operating room

10/783 (1.3)

14/793 (1.8)

Critical care admission

18/783 (2.3)

29/793 (3.7)

1/783 (0.1)

1/793 (0.1)

1.0 (1.0–2.0)

1.0 (1.0–2.0)

Fall within 12 hr after administration of anesthesia
Median time to first ambulation after surgery (IQR) — days‡
Discharge disposition — no./total no. (%)
Home or retirement home

201/777 (25.9)

191/777 (24.6)

Nursing home or skilled nursing facility

347/777 (44.7)

349/777 (44.9)

Rehabilitation or acute care hospital

221/777 (28.4)

229/777 (29.5)

8/777 (1.0)

8/777 (1.0)

Median time to death up to day 60 (IQR) — days§

32.5 (16.0–53.0)

20.0 (7.0–37.0)

Median 12-item WHODAS 2.0 score (IQR)¶

22.7 (8.3–43.2)

18.2 (6.3–31.8)

Worsened walking ability — no./total no. (%)‖

403/672 (60.0)

397/694 (57.2)

Death or transition to new institutional residence
— no./total no. (%)**

108/613 (17.6)

114/625 (18.2)

Hospice or other location
Outcomes within 60 days after randomization

*	Events were classified by site staff as mild, moderate, or severe on the basis of standardized definitions in the manual
of procedures for the trial; data shown indicate all events reported across severity categories.
†	Surgical-site infections were classified by site staff as superficial, deep, or joint-space infections on the basis of standardized definitions in the manual of procedures for the trial; data shown indicate all events reported across infection types.
‡	Data were available for 731 patients in the spinal anesthesia group and 729 patients in the general anesthesia group.
§	Data on time to death were available for 30 patients in the spinal anesthesia group and 31 patients in the general anesthesia group.
¶	The 12-item World Health Organization Disability Schedule 2.0 (WHODAS 2.0) measures disability in six functional
domains (cognition, mobility, self-care, social interaction, life activities, and community participation). Scores range
from 0 to 100, with lower scores indicating lower degrees of disability. Data were available for 225 patients in the spinal anesthesia group and 242 patients in the general anesthesia group.
‖	Worsened walking ability was defined as death, inability to walk without human assistance, or new use of an assistive
device (e.g., cane or walker) at 60 days. Data were available for 672 patients in the spinal anesthesia group and 694
patients in the general anesthesia group.
**	This outcome was assessed among patients who were not admitted from a nursing home, rehabilitation facility, or
acute care hospital (613 in the spinal anesthesia group and 625 in the general anesthesia group). Institutional residence at 60 days was defined as the reported location of residence (nursing home, acute rehabilitation facility, acute
care hospital, hospice, or other location).
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ditional on the other component (vital status), The incidence of new-onset delirium and hospibut we did not conduct a joint modeling analysis tal lengths of stay were similar with the two
because these separate secondary outcomes did types of anesthesia.
The authors, who make up the REGAIN Investigators Writing
not differ between the groups.
assume responsibility for the content of this article.
In the United States, the use of spinal anes- Committee,
The views presented in this article are solely the responsibility
thesia for hip-fracture surgery increased by 50% of the authors and do not necessarily represent the views of the
between 2007 and 2017,2 potentially reflecting a Patient-Centered Outcomes Research Institute, its board of govor its methodology committee.
belief that spinal anesthesia is superior to gen- ernors,
Supported by a grant (1406-18876) from the Patient-Centered
eral anesthesia. Our finding of similar outcomes Outcomes Research Institute.
Disclosure forms provided by the authors are available with
at 60 days with either technique suggests that
text of this article at NEJM.org.
anesthesia choices for hip-fracture surgery may theAfull
data sharing statement provided by the authors is available
be based on patient preference rather than on with the full text of this article at NEJM.org.
We thank the 1600 older adults who volunteered to particianticipated differences in clinical outcomes.
pate in the trial, their families, and the many anesthesiologists,
In this pragmatic randomized trial involving nurse anesthetists, orthopedic surgeons, and research staff
older patients undergoing hip-fracture surgery, members who helped to make the trial a success.
We dedicate this article to the memories of J. Sanford “Sandy”
spinal anesthesia was not superior to general
Schwartz, Eleanor Sokoloff, and Gregory O’Neill, who made imanesthesia with respect to the risk of death or portant contributions to the development and realization of this
new inability to walk independently at 60 days. project.
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